Neuromodulating agents in functional dyspepsia: a comprehensive review
Authors:
- 1 March 2023
- journal article
- review article
- Published by Universa BV in Acta Gastro Enterologica Belgica
- Vol. 86 (1) , 49-57
Abstract
Background and study aims: Functional dyspepsia is a common chronic condition with upper abdominal symptoms in the absence of an organic cause. The first line treatment consists of protonpomp inhibition or Helicobacter pylori eradication. However, this approach often does not provide enough symptom relief. Neuromodulating agents are commonly used in clinical practice but only tricyclic antidepressant (TCAs) are mentioned in European and American and Canadian guidelines. Methods: We performed a comprehensive review of the literature in Pubmed for full-text randomized controlled trials in English with adult participants (>18 years) who met the Rome II, III or IV criteria or were diagnosed by a physician with a negative upper endoscopy and that compared a neuromodulating agent with placebo. Results: The search strategy identified 386 articles of which 14 articles met the eligibility criteria. TCAs like amitriptyline and imipramine have been shown to be effective in the treatment of functional dyspepsia whereas other neuromodulating agents like tetracyclic antidepressants, levosulpiride and anxiolytics might be beneficial but conclusive evidence is lacking. serotonin and noradrenaline reuptake inhibitors (SNRI) and selective serotonin reuptake inhibitors (SSRI) have not shown benefit in patients with functional dyspepsia Conclusion: Selected neuromodulators have an established efficacy in functional dyspepsia. The best supporting evidence is available for TCAs with a potential role for tetracyclic antidepressants, levosulpiride and anxiolyticsKeywords
This publication has 32 references indexed in Scilit:
- Current management strategies and emerging treatments for functional dyspepsiaNature Reviews Gastroenterology & Hepatology, 2013
- The role of psychosocial factors and psychiatric disorders in functional dyspepsiaNature Reviews Gastroenterology & Hepatology, 2013
- Changes in gastrointestinal tract function and structure in functional dyspepsiaNature Reviews Gastroenterology & Hepatology, 2013
- Treatment of functional dyspepsia with sertraline: A double-blind randomized placebo-controlled pilot studyWorld Journal of Gastroenterology, 2012
- Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled studyAlimentary Pharmacology & Therapeutics, 2011
- Effect of the Antidepressant Venlafaxine in Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled TrialClinical Gastroenterology and Hepatology, 2008
- Clinical trial: a randomized controlled cross‐over study of flupenthixol + melitracen in functional dyspepsiaAlimentary Pharmacology & Therapeutics, 2008
- Functional dyspepsia, delayed gastric emptying, and impaired quality of lifeGut, 2005
- A New Pharmacologic Treatment of Functional Gastrointestinal Disorder: A Double-Blind Placebo-Controlled Study with MianserinScandinavian Journal of Gastroenterology, 1996
- The eflects of levosulpiride on gastric and gall‐bladder emptying in functional dyspepsiaAlimentary Pharmacology & Therapeutics, 1994